Incyte; Yale University; ViaLogy; Nanogen | GenomeWeb

Incyte has received US Patent Number 6,316,608, “Combined polynucleotide sequence as discrete assay endpoints. This patent, another addition to the microarray content provider’s venerable intellectual property estate, details methods for determining the relative amounts of specific polynucleotides in a mixture of polynucleotides. In this method, two or more polynucleotides are fluorescently labeled and then combined. These combinations of polynucleotides are anchored to discrete places on an array substrate.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.